Glucagon-like peptide-1 is an incretin hormone, and its analogs and dipeptidyl peptidase-4 (DPP4) inhibitors have been widely used for the treatment of type 2 diabetes mellitus (T2DM) recently. Here, GCG is linked to type 2 diabetes mellitus.